Literature DB >> 1655230

A pathologic study of childhood lymphoma in Taiwan with special reference to peripheral T-cell lymphoma and the association with Epstein-Barr viral infection.

S H Lee1, I J Su, R L Chen, K S Lin, D T Lin, W M Chuu, K S Lin.   

Abstract

The authors retrospectively reviewed the clinicopathologic and immunologic features of 65 consecutive cases of childhood lymphoma reported between 1980 and 1989. Southern blot hybridization was also performed in 23 cases to study their association with Epstein-Barr virus (EBV) and human T-cell leukemia virus type 1 (HTLV-1). The 65 cases included 56 non-Hodgkin's lymphoma (NHL) (86%) and 9 Hodgkin's disease (HD) (14%). The NHL could be classified into the following groups: Group I, small noncleaved cell lymphoma (20 cases); Group II, lymphoblastic lymphoma (17 cases); Group III, large cell lymphoma (17 cases); and miscellaneous (2 cases). There was no follicular lymphoma case. Immunohistochemical study on paraffin sections and/or frozen specimens in 47 cases of NHL showed that all the Group I cases belonged to B-cell neoplasm (17 of 17 cases); most of the Group II cases belonged to T-cell neoplasm (9 of 14 cases); and most of the Group III cases were peripheral T-cell lymphoma (PTL) (8 of 16 cases), including 2 cases of Ki-1 lymphoma. The majority of childhood NHL belonged to high-grade malignancy with an aggressive clinical course (median survival time, 8 months). The EBV DNA could be detected from the tumor tissues in 4 of 6 PTL, but in none of the remaining 19 cases of NHL including 6 Burkitt's type lymphomas. HTLV-1 proviral genome was not detected in all specimens examined. The authors concluded that the distribution pattern and clinicopathologic feature of childhood lymphoma in Taiwan are comparable to that in Japan and western countries. The frequent association of EBV with aggressive PTL was unique and deserves additional investigation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655230     DOI: 10.1002/1097-0142(19911101)68:9<1954::aid-cncr2820680918>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  No evidence of HTLV-I proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphoma.

Authors:  G S Wood; J M Schaffer; R Boni; R Dummer; G Burg; M Takeshita; M Kikuchi
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 2.  Detection and characterization of Epstein-Barr virus in clinical specimens.

Authors:  R F Ambinder; R B Mann
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

3.  Atypical clonal T-cell proliferation in infectious mononucleosis.

Authors:  U R Malik; L Oleksowicz; J P Dutcher; H Ratech; M J Borowitz; P H Wiernik
Journal:  Med Oncol       Date:  1996-12       Impact factor: 3.064

4.  Arsenic in Drinking Water and Incidences of Leukemia and Lymphoma: Implication for Its Dural Effects in Carcinogenicity.

Authors:  Ming-Hsien Lin; Chung-Yi Li; Ya-Yun Cheng; How-Ran Guo
Journal:  Front Public Health       Date:  2022-04-29

Review 5.  The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.

Authors:  A A Gru; B H Haverkos; A G Freud; J Hastings; N B Nowacki; C Barrionuevo; C E Vigil; R Rochford; Y Natkunam; R A Baiocchi; P Porcu
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.